{"id":"W2313376315","doi":"10.1136/annrheumdis-2013-eular.2587","title":"AB0264 Comparison of drug survival, safety and doses of etanercept, infliximab and adalimumab in rheumatoid arthritis patients: thirteen years canadian clinical practice experience.","year":2013,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Credit Valley Hospital","funders":"","keywords":"Medicine; Adalimumab; Etanercept; Rheumatoid arthritis; Infliximab; Drug; Internal medicine; Antirheumatic Agents; Physical therapy; Intensive care medicine; Pharmacology; Tumor necrosis factor alpha","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003304911,0.000294258,0.0007239811,0.0005358426,0.0009893243,0.0008553194,0.0007248872,0.0006478992,0.001301937],"category_scores_gemma":[0.009809168,0.0002278707,0.000506298,0.002142448,0.0004970941,0.000330664,0.0003853374,0.0006888555,0.000233514],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0115215,"about_ca_system_score_gemma":0.01465637,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.7358687,"about_ca_topic_score_gemma":0.7925172,"domain_scores_codex":[0.9977067,0.0005085341,0.0001749559,0.0002224453,0.001160705,0.0002266556],"domain_scores_gemma":[0.9916276,0.002073323,0.001631642,0.0002028971,0.00276085,0.001703667],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.04468388,0.0016442,0.7490496,0.0006984836,0.001253854,0.0005887462,0.003161546,0.001218947,0.003088136,0.0004065984,0.009306376,0.1848997],"study_design_scores_gemma":[0.00223791,0.005597302,0.9826659,0.0001005743,0.0004982337,0.0004416519,0.0007311419,0.0006335226,0.0003424798,0.00006779128,0.006612073,0.00007142292],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9819705,0.01053472,0.000111598,0.0009331396,0.00004135292,0.0001072962,0.00134741,0.00001474516,0.004939223],"genre_scores_gemma":[0.9947632,0.00237133,0.0004425978,0.0002862084,0.0000400151,0.00002702256,0.0009112815,0.000004631929,0.001153872],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2641313,"threshold_uncertainty_score":0.5313736,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0327264314325027,"score_gpt":0.3537514214722969,"score_spread":0.3210249900397942,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}